LEUKOSTRAT
LIVE

Serial Number

86560545

Owner

INVIVOSCRIBE TECHNOLOGIES, INC.

Attorney

Sarah W. Matthews

First Use Date

Feb 12, 2010

Filing Date

Mar 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

LEUKOSTRAT Trademark

Serial Number: 86560545 • Registration: 5628108

LEUKOSTRAT is a trademark filed by INVIVOSCRIBE TECHNOLOGIES, INC. on March 11, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

INVIVOSCRIBE TECHNOLOGIES, INC. (47 trademarks)

10222 BARNES CANYON ROAD
SAN DIEGO, CA 92121

Entity Type: 03

INVIVOSCRIBE, INC. (37 trademarks)

10222 BARNES CANYON ROAD
SAN DIEGO, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 11, 2015

Registration Date

December 11, 2018

First Use Anywhere

February 12, 2010

First Use in Commerce

February 12, 2010

Published for Opposition

August 11, 2015

Goods & Services

Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids

Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use

DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 23, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 23, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 23, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 30, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 11, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 11, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 3, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 2, 2018 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 24, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 24, 2018 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 24, 2018 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 13, 2018 SUPC
USE AMENDMENT FILED
Sep 11, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 11, 2018 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 5, 2018 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 17, 2018 EXRA
SOU EXTENSION 5 GRANTED
Apr 16, 2018 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 3, 2018 AITU
SOU EXTENSION 5 FILED
Mar 30, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 30, 2018 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 28, 2018 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2017 EXRA
SOU EXTENSION 4 GRANTED
Sep 26, 2017 EX4G
SOU EXTENSION 4 FILED
Sep 26, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 26, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2017 EXRA
SOU EXTENSION 3 GRANTED
Mar 29, 2017 EX3G
SOU EXTENSION 3 FILED
Mar 29, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 29, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2016 EXRA
SOU EXTENSION 2 GRANTED
Oct 26, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 26, 2016 AITU
SOU EXTENSION 2 FILED
Oct 4, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 4, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2016 EXRA
SOU EXTENSION 1 GRANTED
Mar 25, 2016 EX1G
SOU EXTENSION 1 FILED
Mar 25, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 25, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 6, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 11, 2015 NPUB
PUBLISHED FOR OPPOSITION
Aug 11, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 22, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 4, 2015 PREV
ASSIGNED TO LIE
Jul 2, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2015 CNSA
ASSIGNED TO EXAMINER
Jun 16, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2015 NWOS
NEW APPLICATION ENTERED
Mar 14, 2015 NWAP